Clinical Study Between Two Clindamycin 1%/Benzoyl Peroxide 5% Topical Gels

A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study to Compare Perrigo Israel Pharmaceuticals, Ltd., Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel to a Comparator Clindamycin / Benzoyl Peroxide Topical Gel, and Both Active Treatments to a Vehicle Control in the Treatment of Acne Vulgaris

The purpose of this study is to compare the efficacy and safety profiles of Perrigo Israel Pharmaceuticals, Ltd. Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel and Benzaclin® Topical Gel (Clindamycin- Benzoyl Peroxide Gel).

Inclusion Criteria:

• Healthy men or women, 12 to 65 years of age
• Willing to participate and sign provide written consent
• Moderate to severe acne

Exclusion Criteria:

• Pregnant or lactating women
• History of unresponsiveness or hypersensitivity to clindamycin, benzoyl peroxide or lincomycin
• Use of systemic, topical or facial products which may interfere with the study
• Participation in any clinical study in the 30 days prior to study entry
• Prolonged exposure to sunlight or excessive exposure to UV lights
• Chronic use of NSAIDS